These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12579280)

  • 1. Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells.
    Sauer G; Kurzeder C; Grundmann R; Kreienberg R; Zeillinger R; Deissler H
    Oncol Rep; 2003; 10(2):405-10. PubMed ID: 12579280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD82, and CD63 in thyroid cancer.
    Chen Z; Mustafa T; Trojanowicz B; Brauckhoff M; Gimm O; Schmutzler C; Köhrle J; Holzhausen HJ; Kehlen A; Klonisch T; Finke R; Dralle H; Hoang-Vu C
    Int J Mol Med; 2004 Oct; 14(4):517-27. PubMed ID: 15375577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetraspanin gene expression levels as potential biomarkers for malignancy of gingival squamous cell carcinoma.
    Hirano C; Nagata M; Noman AA; Kitamura N; Ohnishi M; Ohyama T; Kobayashi T; Suzuki K; Yoshizawa M; Izumi N; Fujita H; Takagi R
    Int J Cancer; 2009 Jun; 124(12):2911-6. PubMed ID: 19330835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer.
    Funakoshi T; Tachibana I; Hoshida Y; Kimura H; Takeda Y; Kijima T; Nishino K; Goto H; Yoneda T; Kumagai T; Osaki T; Hayashi S; Aozasa K; Kawase I
    Oncogene; 2003 Feb; 22(5):674-87. PubMed ID: 12569360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tetraspanins in peripheral blood leukocytes: a comparison between normal and infectious conditions.
    Tohami T; Drucker L; Radnay J; Shapira H; Lishner M
    Tissue Antigens; 2004 Sep; 64(3):235-42. PubMed ID: 15304003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
    Zhou B; Liu L; Reddivari M; Zhang XA
    Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.
    Wang JC; Bégin LR; Bérubé NG; Chevalier S; Aprikian AG; Gourdeau H; Chevrette M
    Clin Cancer Res; 2007 Apr; 13(8):2354-61. PubMed ID: 17406028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma.
    Buim ME; Lourenço SV; Carvalho KC; Cardim R; Pereira C; Carvalho AL; Fregnani JH; Soares FA
    Oral Oncol; 2010 Mar; 46(3):166-71. PubMed ID: 20060356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the tetraspanins CD9, CD37, CD63, and CD151 in Merkel cell carcinoma: strong evidence for a posttranscriptional fine-tuning of CD9 gene expression.
    Woegerbauer M; Thurnher D; Houben R; Pammer J; Kloimstein P; Heiduschka G; Petzelbauer P; Erovic BM
    Mod Pathol; 2010 May; 23(5):751-62. PubMed ID: 20118909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins.
    Rubinstein E; Le Naour F; Lagaudrière-Gesbert C; Billard M; Conjeaud H; Boucheix C
    Eur J Immunol; 1996 Nov; 26(11):2657-65. PubMed ID: 8921952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of CD151 gene expression in non-small cell lung cancer.
    Tokuhara T; Hasegawa H; Hattori N; Ishida H; Taki T; Tachibana S; Sasaki S; Miyake M
    Clin Cancer Res; 2001 Dec; 7(12):4109-14. PubMed ID: 11751509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility.
    Gesierich S; Paret C; Hildebrand D; Weitz J; Zgraggen K; Schmitz-Winnenthal FH; Horejsi V; Yoshie O; Herlyn D; Ashman LK; Zöller M
    Clin Cancer Res; 2005 Apr; 11(8):2840-52. PubMed ID: 15837731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetraspanin CD9 is involved in the migration of retinal microvascular endothelial cells.
    Deissler H; Kuhn EM; Lang GE; Deissler H
    Int J Mol Med; 2007 Nov; 20(5):643-52. PubMed ID: 17912457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with alpha 3 beta 1 integrin.
    Okochi H; Kato M; Nashiro K; Yoshie O; Miyazono K; Furue M
    Br J Dermatol; 1997 Dec; 137(6):856-63. PubMed ID: 9470900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KAI1 protein is down-regulated during the progression of human breast cancer.
    Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M
    Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
    Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
    Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel molecular staging protocol for non-small cell lung cancer.
    Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
    Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
    Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
    Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.
    Huang CI; Kohno N; Ogawa E; Adachi M; Taki T; Miyake M
    Am J Pathol; 1998 Sep; 153(3):973-83. PubMed ID: 9736046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.